JPRN-UMIN000007014招募中2 期
Investigation of the Efficacy of Pre-operative Endocrine Therapy with Toremifene cirate and Exemestane for Postmenopausal Breast Cancer Patients - Investigation of the Efficacy of Pre-operative Endocrine Therapy with Toremifene cirate and Exemestane for Postmenopausal Breast Cancer Patients
Japan Breast Cancer Research Network0 个研究点目标入组 25 人开始时间: 2012年1月4日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable(—)
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. Inflammatory breast cancer 2. Active double cancer 3. Severe heart diseases including myocardial infarction, cardiac insufficiency or patients who have a medical history in these diseases 4. Medical history in deep vein thrombosis 5. Cirrhosis 6. Fever with more than 38 degree 7. Patients who have bleeding tendency 8. Patients who are judged as ineligible for the study enrollment by investigators
研究者
相似试验
已完成
1 期
Evaluation of the effectiveness of the preoperative administration of a single-dose preparationof azithromycin, in chest surgery.primary lung cancerJPRN-UMIN000010368Surgical Oncology, Nagasaki University Hospital50
已完成
不适用
Investigating the effectiveness of a pre-operative education intervention on reducing anxiety and improving recovery among Chinese cardiac patientsAnxietyISRCTN87451169niversity of Nottingham (UK)125
尚未招募
2 期
comparing efficacy of preoperative magnesium sulphate nebulization with ketamine nebulization in reducing incidence of severity of post operative sore throat in patient undergoing surgery under general anesthesia.,CTRI/2024/04/065794dr vaishnav
尚未招募
不适用
Effect of preoperative sildenafil on patients with severe pulmonary hypertension undergoing heart valve replacement.Pulmonary HypertensionACTRN12611000267954Richard Renew50
招募中
2 期
Assessment of the Efficacy of Preoperative Exemestane Therapy for Endocrine-sensitive Postmenopausal Breast Cancer (SBCCSG-23)Breast cancerJPRN-UMIN000006453PO Saitama Breast Cancer Clinical Study Group (SBCCSG)60
